2017
Nine‐month results of the BIOHELIX‐I clinical trial study: Evaluation of the PRO‐Kinetic Energy cobalt chromium bare‐metal stent system
Michael TT, Richardt G, Lansky A, Carney RJ, Khan MA, Shehadeh A, Zeymer U, Gupta S. Nine‐month results of the BIOHELIX‐I clinical trial study: Evaluation of the PRO‐Kinetic Energy cobalt chromium bare‐metal stent system. Catheterization And Cardiovascular Interventions 2017, 92: 1030-1039. PMID: 29271575, DOI: 10.1002/ccd.27434.Peer-Reviewed Original ResearchConceptsTarget vessel revascularizationCoronary artery diseaseIschemia-driven target vessel revascularizationBare metal stentsTarget vessel failureTVF ratePrimary endpointStent systemSymptomatic coronary artery diseaseTarget lesion revascularization rateSingle-arm clinical trialNine‐month resultsDual antiplatelet therapyLesion revascularization rateMean patient agePercutaneous coronary interventionSubset of patientsClinical trial studyPrespecified performance goalArm clinical trialCoronary stent systemDrug-eluting stentsMean lesion lengthMajority of implantsEligible patients
2002
Does vessel size have an impact on recurence rates following gamma vascular brachytherapy: acute and nine-month results from SCRIPPS III registry
Adamian M, Mehran R, Dangas G, New G, Abizaid A, Lansky A, Weisz G, Grise M, Collins M, Kreps E, Stone G, Moussa I, Moses J, Leon M, Teirstein P. Does vessel size have an impact on recurence rates following gamma vascular brachytherapy: acute and nine-month results from SCRIPPS III registry. Journal Of The American College Of Cardiology 2002, 39: 64. DOI: 10.1016/s0735-1097(02)80277-7.Peer-Reviewed Original Research